Hi y’all,
Home Dialysis Plus is still trucking along!
Portland, Ore., Oct. 28, 2008 - Home Dialysis Plus, Ltd. (HD+), a developer of advanced home dialysis devices, announces Dr. Julie Wrazel, to take position as Chief Technical Officer. As CTO she will lead the development of a portable, cost-effective hemodialysis system that will allow patients to experience the benefits of nightly nocturnal dialysis in their own homes.
Dr. Wrazel joins HD+ after 29 years of employment with Hewlett-Packard. As a key R&D and Process Development Manager within HP’s inkjet printing business, Dr. Wrazel was specifically responsible for the development of the micro-fluidic devices and achieving the exponential production growth rates demanded by a successful supplies business.
“Taking a key position with a company that has the potential to impact the lives of millions of people is not only a tremendous opportunity, but a responsibility I look forward to,” says Wrazel. “It’s quite exciting to be applying firsthand knowledge of micro-fluidics technologies to this new medical application.”
The HD+ system utilizes recently licensed HP inkjet and smart memory chip technologies, along with HD+ patented MECS (Micro-scale Energy and Chemical Systems) technologies for use in the dialyzer and water pasteurization system.
“With multiple unique micro-scale systems within the HD+ system, Dr. Wrazel’s micro-fluidics and high volume manufacturing expertise will prove to be of critical benefit not only to our company, but ultimately to the patients who use the device.” Says Michael Baker, HD+ CEO, “We are fortunate to have such an experienced, high caliber professional on our team.”
As a result of these combined advanced technologies within the HD+ system, dialysis patients are expected to experience a slower, gentler night time treatment which is a closer simulation of the body’s natural biological processes. This will improve patients’ dialysis results and dramatically reduce patients’ post-treatment recovery time. The ability to sleep during treatment will allow for improved flexibility and more day to day lifestyle control.
The technology also makes it possible to create a significantly smaller and patient friendly dialysis machine. The reduced size will make portability a viable option for patients as the HD+ system will be easy to use at home or anywhere else that has access to tap water. For health care providers, the dialysis machine will make it simple and less expensive to train patients and their care helpers to safely perform home treatments.
About Home Dialysis Plus, Ltd. (HD+)
Home Dialysis Plus, Ltd. (HD+) is focused on the advancement of home hemodialysis treatment for patients suffering from End Stage Renal Disease. Via the use of patented MECS technology, the company aims to produce home treatment options that will offer improved health outcomes through ultra patient-friendly, portable hemodialysis machines. For more information please visit Home Dialysis Plus, Ltd.
About Dr. Julie Wrazel
After a 29 year history with HP, Dr. Wrazel is an expert in micro-fluidic design and processes with a critical understanding of high volume manufacturing and supply chain management. Cultivating her technical and managerial responsibilities within the growth of HP’s inkjet printer business, Dr. Wrazel has held multiple executive positions including Strategic Alliance Manager for key partnerships within the Imaging and Printing Group. Holding a Ph.D. in Chemistry from the University of Wisconsin and an MS in the Management of Innovation, Dr. Wrazel is a sought after speaker for workshops and programs on the subject of alliance management and open innovation.
This news release contains forward-looking statements that involve risks, uncertainties and assumptions. If such risks or uncertainties materialize or such assumptions prove incorrect, the results of HD+ and its consolidated subsidiaries could differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to statements of the plans, strategies and objectives of management for future operations; any statements concerning expected development, performance or market share relating to products and services; anticipated operational and financial results; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing. HD+ assumes no obligation and does not intend to update these forward-looking statements.
Editorial Contact:
Brenda Edin Home Dialysis Plus, Ltd. 503.528.6296 brenda@homedialysisplus.com